2016
DOI: 10.1016/j.fjps.2016.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
28
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(29 citation statements)
references
References 99 publications
1
28
0
Order By: Relevance
“…The IR spectra (KBr) were recorded on a Perkin Elmer 1650 spectrometer (Shelton, CT, USA). 1 H-NMR and 13 C-NMR spectra were recorded on a JEOL EX-300 and JEOL ECA-500 (Shimadzu, Tokyo, Japan).…”
Section: General Informationmentioning
confidence: 99%
See 1 more Smart Citation
“…The IR spectra (KBr) were recorded on a Perkin Elmer 1650 spectrometer (Shelton, CT, USA). 1 H-NMR and 13 C-NMR spectra were recorded on a JEOL EX-300 and JEOL ECA-500 (Shimadzu, Tokyo, Japan).…”
Section: General Informationmentioning
confidence: 99%
“…Pyrazolopyrimidines have important biological functions including herbicidal [12] and antitumor activity [13]; pyrazolopyrimidine derivatives have been found as purine analogs [14] and have significant properties as antimetabolites in purine biochemical reactions such as neuropeptide Y1 receptor antagonists [15]. Also, the pyrazolo [4,3-d]pyrimidinone class of compounds is very important in the treatment of impotence [16], used as an PDE5 inhibitor.…”
Section: Introductionmentioning
confidence: 99%
“…Pyrazolo [3,4-d]pyrimidine nucleus is the bioisostere of purine [4] [5], which exhibits promising activity as antitumor by competitive inhibition for ATP kinase enzymes. Many pyrazolo [3,4-d]pyrimidine derivatives were reported as antitumor agents [6] [7] [8]. The cytotoxic activity of such compound may attribute to inhibition of several enzymes such as tyrosine kinase [9], Src kinase [10], cyclin dependent kinase (CDK) [11], mammalian target of rapamycin (mTOR) [12] and glycogen synthase kinase (GSK) [13] [14].…”
Section: Introductionmentioning
confidence: 99%
“…Hence exhibits promising activity as antitumor by competitive inhibition for ATP kinase enzymes. Many pyrazolo [3,4-d]pyrimidine derivatives were reported as antitumor agents [6][7][8]. The cytotoxic activity of such compound may attributed to inhibition of several enzymes such as tyrosine kinase [9], Src kinase [10], cyclin dependent kinase (CDK) [11], mammalian target of rapamycin (mTOR) [12] and glycogen synthase kinase (GSK) [13,14].…”
Section: Introductionmentioning
confidence: 99%